Criteria for Discharging a Patient with Alcohol Withdrawal

Assessment Before Discharge

Patients with alcohol withdrawal can be safely discharged when they have stable vital signs, resolution of withdrawal symptoms (CIWA-Ar score <8), no complications requiring inpatient care, and a comprehensive follow-up plan in place, as recommended by the American Association for the Study of Liver Diseases 1, 2
Ensure complete resolution of withdrawal symptoms using validated tools like the CIWA-Ar scale, with scores consistently below 8 indicating mild or resolved withdrawal, according to the Clinical and Molecular Hepatology guidelines 1, 2
Verify stable vital signs with no tachycardia, hypertension, or fever for at least 24 hours, as suggested by the Clinical and Molecular Hepatology 2
Confirm absence of complications such as seizures, hallucinations, or delirium tremens, as recommended by the Clinical and Molecular Hepatology 2
Screen for psychiatric comorbidities that may require specialized follow-up care, as advised by the American Psychiatric Association 3, 4

If benzodiazepines were used for withdrawal management, ensure the patient has completed the prescribed course (typically 5-7 days) or has been appropriately tapered, as recommended by the American College of Clinical Pharmacology 5
For patients with hepatic dysfunction who received short-acting benzodiazepines (lorazepam, oxazepam), verify medication has been appropriately discontinued, according to the Journal of Hepatology guidelines 1, 2
Ensure the patient has received adequate thiamine supplementation (100-300 mg/day) and has a prescription to continue for 2-3 months post-discharge, as suggested by the Clinical and Molecular Hepatology 2
Consider prescribing medication for relapse prevention (naltrexone, acamprosate, or baclofen) only after complete detoxification, not during active withdrawal, as recommended by the American Society of Addiction Medicine 5

Begin discharge planning at least 24-48 hours before anticipated discharge, as advised by the American Diabetes Association 6
Supply medications adequate to last until the first post-discharge appointment, as recommended by the Diabetes Care guidelines 6
Arrange referrals to outpatient treatment programs and support groups, as suggested by the American Association for the Study of Liver Diseases 3

For patients with history of severe withdrawal (seizures, delirium tremens), consider longer observation periods before discharge, as recommended by the Journal of Hepatology guidelines 1, 2
Patients with significant psychiatric comorbidities should have psychiatric follow-up arranged prior to discharge, as advised by the American Psychiatric Association 3, 4
For patients with liver disease, ensure they have appropriate hepatology follow-up, as recommended by the American Association for the Study of Liver Diseases 1, 2

Overlooking concurrent substance use disorders that may complicate recovery, as warned by the American Association for the Study of Liver Diseases 3, 4
Prescribing benzodiazepines for longer than necessary (beyond 7-14 days), which increases risk of dependence, as cautioned by the American College of Clinical Pharmacology 1, 5